Investors

Corporate Profile

Elicio Therapeutics is a clinical-stage biotechnology company engineering investigational lymph node-targeted vaccines for an array of aggressive cancers and infectious diseases.

Investor Relations Contact

Heather DiVecchia
Elicio Therapeutics
Tel: (857) 209-0153
IR@elicio.com

Email Alerts Sign-Up